. L . J a n u a r 196 5 K F K 295 Y I n s t i t u t f ü r S t r a h l e n b i o l o g i e R e t e n t i o n o i R a d i o c a e s i u m b~ t h e R a t a s I n f l u e n c e d b \ $ 1. INTROD~CTION 13'Cs nlust be considered as a potentially hazardous radionuclide and a considerable amount of b o f k~ has been done aiming a t the enhancement OS 137Cs-excretion. Slightly higher urinary excretion rates were observed by Kurlandskaya (1957) arid Ogawa, &fachida, Suzuki and Shibata (1938) following the administration of stable Cs-salts; however, 3loskalev (1961 b) fttiled to confirm this finding. The excretion of 13'Cs in rats was enhanced by increasing the potassium content of the diet (Richmond and Furchner 1961 b, Wasserman, Comar and Tapper 1963); a similar effect, however, hus not been observed in humans (McKeill, Green and Rapoport 1962). The failure of the chelating EDTAto raise the urinary e~cretion (Fateyeva, Klimov, Ponizovskaya, Gorbarenlro; Sokolov and Smirnova 1960) is not surprising, due to the poor CO-ordinating properties of the alkali meta1 ions. Continuous administration of the diuretic Diamox reduced the body burden of 13iCs in small rodents to approximately 70% of the control (Richmond and Furchner 1961 a); however, in humans dillretics proved
to be ineffective (Rosoff, Cohn and Spencer 1963) . A detailed enumeration of all other pharmaceuticals, hormodes, etc., which have been tested without positive results, cail be omitted. d promising approach is offered by the fact that the f&cal escretion of 13' Cs is rather lorv (Noslialev 1961 a) despite its fairly high secretion into the intestinal tract (Moore and Coinar 1962) . , Obviously, a reabsorption of 13iCs has to be assumed and it could be anticipated that an interruption of this ' enteral cycle ' mould raise tlie faecal escrction of 13iCs. In Iieeping with this assiimptioil, Xraz and Patrick (1957 b) have demonstrated a distinct effect in animals rnaintaiiied on a diet containing bentonite or veriniculite: uith orally and paienterally admiiiistered 13'Cs, the body-burden was reduced to 70 and 80% of the control value, respectively. The iiet effect, though interesting from the theroretical riempoint, is disappointingly sxnall, and it is qiiestioilable wlietlier tlie cornpounds referred to above are the optimal ones. Summing up, it can be stated that, so far, no antidotes are arailable for the treatmetit of internal contamination mith 13'Cs.
The main accent of the preseiit inrestigation lies on the search for agents able to bind effectively 137Cs in the intestines and, in particular, on the elucidatiori of the efficacy pattern of ferric ferrocyanide, a compound which iri preliminary screening tests yielded rather pronlising results (NigroviC 1963) .
2. MATERIAL ARI) METHODS
Carrier-free 13iCsC1 ( 2 pc; pH 2.5) was administered to albino rats of both seses either by gastric intubatiori or by intraperitoneal injectioil. The animals, 12 to 20 weeks old, were fasted for 20 hours prior to tlie oral administration. If iiot stated otherwise, the diet consisted of standard pellets (1 jo potassiuin) and water ad libitum. The retention of 13'Cs was followed by wliole-body couriting: a plastic sciiitillator (T in. diam., 5 in. deep) was used. The activity, which was measiired immediately after tlie administration of 13;Cs, was taben as 1000,{,. Coiistarit counting efficiency was assured by assaying standard 137Cs-sainples. Screening experiments demoristrated t,hat the position of the rat in the plastic tube ( G cm diam., 17.5 cm long, wall-t'liickness 0.5 cm) used did not irifluenee the counting rate. The tube-to-scintillator distance was 19 cm.
All chemicals used were of analytical grade. The different insoluble metal salts of ferrocyaiiic acid were prepared by addition of the corresponding metal salt to potassiuin ferrocyanide solution in the appropriate molar amounts. The precipit'ates were separated by centrifugation, washed witli distilled water, dried and pulverizecl.
The 137Cs-content of the body was expressed either as percentages of tlie administered 137Cs-amount, or as percentages of tlie coiitrol, i.e., tlie 13iCs-conteiit of untreated animals; each single experimental series coiitained its o~vn control group. The number of rats per experimental group varied froin G to 10. s 3. R E S~L T S The first esperiments were designed to find tlie compounds with the greatest ability to bind 13'Cs in the intestinal tract, either by precipitation, absorption, or by ion-exchange. Carrier-free 137Cs and, immediately thereafter, the compound to be tested were administered by gastric tube. Sodium perchlorate, sodium-potassiuiii tartratc, sodiurn cobaltiriitrite, zirconium phospliate, magnesiuni tiisilicate, alumiiiium oxide, Graham's salt, Don~ex A, and polyacrilic acid, had no significant effect on the ahsorptioii of 13'Cs, and a detailed presentatiori of the resiilts is omitted.
It may be mentioried only that the ability of Dowex A to bind I3'Cs in vitro proved to be high. so that oiie may assume that tlie bindiiig is not stable enough in vivo, when the presence of riunierous corii1)eting ions in the intestinal tract has to be taken into accourit.
Bs can be seen from table I , sodium tetrapheiiylborate defiiiitrly reduces tJhe absorptjon of I3'Cs. In ordm to be effective this conlpound must be administered a t the same time as the 13'Cs. Tlie efficacy is reduced when the administratiori was postponed even for 30 secorids (experiment B, table I ) , becoming virtually negligible a t greater intervals (data not presented). Fig. 1 summarizes the results of the esperiments n-here oral or intraperitoneal adniinistratioii of 13'Cs V-as follo~ved after different tiine intervals by oral adinini~trat~ioii of ferric ferrocpriide (Priissian Blue, PB). TTith orally admiiiistered 13'Cs, there is a sharp dirninut,ioii of effectireness duriiig the first t1i70 hours, whereas n-it'h iiitra,peritoneally injected 13'Cs the time-dependeilce is less proiiounced. Obviously, the efficacy of P B admiiiistered after tliree hours does not depend upoil the lnode of administration of 13'Cs; in both cases, tlie body-burdeii is reduced to betnreen 80 and 907; of the control. Fig. 2 compares tlie effectiveness of P B and of the watei-soliible potassium ferrocyaiiide a t different dose-lerels. Potassium ferrocyaiiide, though effectire in lo~ireririg tlie absorption of I3iCs, is defiiiitely inferior to PB.
On the other hand, potassiuin ferrocynnide (10 nig!aiiinial) iiijected intraveiiously and simultaneously with 13'Cs, leads to a diniinislied elimination of I3'Cs; the body-burdeii oii the 7th da? beirig 70.5 5 1.570 as compared witli 49.0 5 1.5'$/, in the corit,rol group.
As can be seen from table 2 , there is iio sigiiificaiit differeiice bet,weeii tlie efficacy of 1' B prepared frorn sodiuiii aiid froin potassiuni ferrocyanide. Separate administration of FeCI, aiid potassiiiiii ferrocyaiiide (iri a riiolar ratio of 3 : 3), n-liich shoilld be follon-ed by tlie precipitat'ion of P B in the st'oiiiacli, is defiiiitely less effective tliaii PB. B reduced effectiveness was also observed for the other rnet,al salts of ferrocyaiiic seid enumerated iii fig. 1 , less effective. The poor effectiveness of the t~v o highest dose-levels may be ascribed to the significantly reduced consumption of water by the rats. Also, a marked loss of body weight was noted in these groups.
The relatively long duration of the PB-experiment (i.e., 17 days) makes it possible to determine the influence of P B on the retention function of
Fig. 2. Iduence of different doses of potassium ferrocyanide (PFC) and
Prussian Blue (PB) on the body-burden of 13' Cs (on t,he 4th day). Both compounds were given orally immediately after oral administration of 137Cs. The vertical bars indicate fiducial limit,s (P=0.05).
13'Cs. I n all the experimental groups the dependence of the body-burden ( B ) upon time (t, in days) can be fitted satisfactorily by the multiexponential expression R=a, exp ( -A,t)+a,exp ( -X-t).
I n untreated animals, a , equals 250,; of the administered 137Cs-amount and is excreted with a half-time of approximately 1 day, whereas the residual 75% (U,) are eliminated with a half-time of 8.5 days. The administration of P B exerts, as can be Seen from fig. 4 , a twofold influence: it decreases U , and increases A,. Tlie increase of PB-dosage, ho~vever, gires rise to a slight increase of efficacy only. Since no attempts were made in the preceding experiments to determine the consumption of food and, thus, the actual intake of PB, in anotlier experiment PB was given by gastric tube twice daily (9 a.m. and 5 p.m.).
The treatment schedule was varied as indicated in fig. 5 . The slope of the retention curves in all PB-treated groups is identical and independent of the time when treatment was started; after cessation of treatment the curres ran parallel wit,h the control. The retention in the control group This is in contrast to the preceding experiment ( fig. 4 ), ~vhicli demonstrated a significant decrease of U, under the influence of PB. An essential prerequisite for obtainirig a inaximal effect iiiider clironic experimeiital conditions is tlie proper spaciiig of multiple closes of PB. As cari be seeii froiii fig. G the sanie total close is sigiiificaiitly niorc cffectire xvheii it is divided in t,wo ecjual doses separated 1üy : ! to 4 lioiirs.
Fiiially, i t niay be stressed tliat in all esperiinents iio tosic side effects of PB were ~ioted. Even coiitinued treatnieiit witli high dosages (50 mg twice daily for 1 I days) was weil tolerated, aiicl iio loss of bodj--\veight was observed.
% 4. D I~C C S S I~S
I t lies beyoild tlic scope of tliis study to discuss iii detail tlie iiiechaiiisili by n-liich PB binds CS' , aiid pertiiierit piiblicatioiis dealiiig with this questioii are referred to (Kyrsli and Zryagiiitsev 1058. l'uslikarer Slirylev aiid Bagretsov I!)GO: Rogiiisliiy, ?tIaliiiiiia, Taiiovsliij~. A41tsliuler aiid JIorokhorets i960). Siiice the cq-stnl lattice of 1'13 coiitaiiis coiisiclerable amouiits of'potassiuiii. ioii-escliaiige is niost likely inrolved*. This is coiii1)atible V-ith tlie fact tliat an iiicrease of' tlie C's-coticeiitrntioii, i.e.. isotopic dilutioii of Ix'Cs$ is follon-ed by a decrease of PB-efficacy (tablr 3). Xlthough otlier ii~etal salts of ferrociyaiiic acid biiicl Cs-. probably. in tlie sailie n-ay as P B , tlie reasoii for their lo~ver efficacj-is not yet clear: tlirir solubilitics are distiiictly liigher thaii that of I'B (Taiiaiiayer, C;lilshliora aiid Seifer 103(i), but tliese differeiices are iiot proiiouiiced eiioiigli to play a sigiiificaiit role. , 411 esseiitial fcatiire is tliat tlie effectil-eiicss of PB reniairis coristatit irrespectiw of the time nlieii treatiileiit is started. aiid thnt tlit iiet effect is 13roportioiial t o tlie diiratioii of trcatinciit. l'iiis is ralicl. at least, for tlie first n-eeks follon-iiig iiicorl)orntioii of lK;Cs. ;\laximal efficacy caii bc a<*hiereci oiily if an optimnl aiid c»u.ctn~t coiicentratioil of PR is inaiiitaiiicd iii tlie \vliolc iiitestiiial trnct. l'liis is Eody-burden (7; of control and fidiicial liri~its (P=0.05) ) ori tlic 4th da' -exemplified by tlie results sho~vri in fig. 6 . For technical reasons (in the experiment where PB was given by gastric tube), and berause of the irregiilar coiisumption of food by the rats, there can be no doubt tliat the largest obtaiiiable effect was not achieved in oui experiments. In spite of this, the actually observed effect, i.e., reductioii of the bodg-burclen by 80 to 85O/" is fairlg high arid compares n-ell witli tlie results obtairied n-itli other iadioiliiclides by the use of specific cl-ielatiiig ageiits. I n rieu. of the high efficacy as well as the complete lacli of aiiy toxic side effects, PB miist be considered as a valuable antidote iri cases of accidental internal contamiiiation with 13iCs. -4s to tlie usage of I'B iri liumans, it cari bc reasonablg anticipated tliat it will exert a si~nilar effect to that seen in rats, if \Te are dealiiig with tlie ingestioa of 13'Cs. 'Cl'hetlier this is valid for a purenteral coiitariiinatioii is not yet clear, siiice tlie enteral secretion rate in huniaiis is not get kiio~vn. ,41tliougli the ratio of faecal to urinary 13iCs-excretioii in huinans is, by aiid large, comparable to tlie iatio in rats (Rosoff et al. 1963 , JIraz aiicl Patrick 1957 a), the net excretion is clefiiiitely lower. Experiiiieilts aiming a t the elucidation of tliis question as well as oii tlie elaboratiori of aii optiiiial dosage and treatriieiit sclietlule are iirgently rieeded.
l\'e U-isli to thaiik Jliss H. Recliert aiid Miss I). Doiiiprobst for sliilfiil techriical assistailce. Sodiurn tetrapheriylborate (Kaligiiost) was obtaiiied by eourtesy of Heyc aild Co., Berlin-Steglik.
Ttie c~ffcctiveiit:as of scveral coriipoiinds iri suppressirig tlie enteral alrsorptioii cif 13'Cs in rilti; was testcd. All agtxIits were fouiitl t o Lc iiirfft~rtive, n-itli tlie exceptioii ofso<liiim tetraplienylborate. potassiuin Eerroq-anitir arid, iii pnrticular, ferric ferroc.yanitle (I'riissian 131ue). Tlie decreüse in entcrtil absorptioii of 13'Cs 1)'-oral ntlrriinistruti«ii of 1% 1s <lcl)critlent upon (lose a n d tiine of atlini~iistratioii. Tlie iriasiirial cftect nrliievetl is tlie reductiori of t h e body-t~urderi b y 90°0. He~pr.atet1 oral atliiiinistratioii of I' L3 also riitiaiirc~s siil)st;~ritially the escretioii of pareritcrally administerctl '"Cs Tliis eftivt 1%-as fouiicl tu bc iridt~~>eritlciit on tlie time v,lien treatiiieiit was startrtl. S n toxir sitle cfliacts of PB 1rci.t. ol>serretl.
L'iriflucnce de Bleu tle I'russe r t (l'autrrs r«mpo,i.s sur la r6tcntion dc ruclio-c6siuin par le rat.
Ori a ¿tudi¿. l'cffrcacit4 de plusieurs sulrstanres en r e qui coticcriie 1s s u~] w c w~~) i i (le I'absorption intestinale d u '3'Cs cliez le rat. L s plupart des ageiits se soiit ri.vel&s incfiirnc.es & l'c,xception d u t&traphenylt~orate d e sodiurn, tlu forrocyanute de potassii~in o t en particulior d u ferrrrcyanatc ferrique (PD). Le PB, ndministr6 pur voie orale, r6duit l'absorptioii iiitestinale d u 13'Cs en foriction d e lo, rlose e t dii teinps. L'effot inasiirium obtenu a 6t6 iiiie r6durtiori de 09 pour cent de l'absorptiori. Des doses ropetees reduisent aussi coiisi<lGrnl>le-merit la retcntion du CS injecte Par voie parenterale. Cet effet n e depend pus dc l'iritcrvalle d e teinps eiltrc l'irijection du 13'Cs c t 1e t r a i t e~n e~i t .
I,e PB n'a preseiite nucuii ~f f e t toxique secondaire.
Retention of Radiocuesiurr~ 9 1
Die Einwirliung vor1 Uerliiiorhlau und anderen Verbindungen auf die Retention von Radiozasium im Ratte:iliörper.
E s wurde der Eirifluss verschiedener Substanzen auf die enterale Resorption von 13:Cs bei der Ratte untersucht. Alle Substanzen erwiesen sich als unmirksairi mit Ausrtahme von Xntriuintetraphcr1~1br>rat, Iialiumcyanoferrut (11) 
